Trials / Completed
CompletedNCT05075850
PatiEnt Neuropsychological outcomeS After laseR Ablation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 81 (actual)
- Sponsor
- Monteris Medical · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- —
Summary
PatiEnt Neuropsychological outcomeS After laseR ablation
Detailed description
This is a multicenter sub-study that will include comprehensive neuropsychological assessment data collection done at baseline (within 1 year prior to the index LITT procedure) and at follow-up (at least 6 months from the index LITT procedure). Visual field testing will be conducted in a subset of enrolled patients. Up to 250 subjects may be enrolled at up to 15 study sites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Neuroblate System | All subjects will undergo comprehensive neuropsychological assessment post-LITT per standard of care practice. Visual field testing will be conducted in a subset of enrolled patients. |
Timeline
- Start date
- 2021-09-29
- Primary completion
- 2023-09-30
- Completion
- 2023-09-30
- First posted
- 2021-10-13
- Last updated
- 2025-04-06
- Results posted
- 2025-04-06
Locations
7 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05075850. Inclusion in this directory is not an endorsement.